2138太阳集团(中国)有限公司-Official website

3358288340
CN
CN EN
R&D Fields
Research Institute R&D Fields Quality Control
Explorations R&D Fields
R&D Fields
In order to meet clinical needs, we adhere to a product strategy combining in-depth exploration in technical advantages with expansion in cutting-edge biotechnology. Our R&D works will focus on "recombinant proteins and microecological agents" in the near future, and then "antibody drugs" in the middle and later periods. Meanwhile, we will also accelerate the project reserve in cutting-edge biotechnology, such as cell therapy, gene therapy, gene vaccination and biological testing, and incubate innovative drugs-based new technology platforms.
R&D Fields
TOP
About Us
Explorations
Products
Careers
CSR
CSR Mechanism
Patient Education
Public Responsibility
News Center
Latest News
Media Downloads
Video Center
Contact Us
Contact Us
Online Message
Information for medical professionals only.
Internet Drug Information Service Certificate Number: (Lu)-non-commercial-2018-0066

All contents © Copyrights 2019 Kexing Biopharm.(Lu) ICP Reg No.: 19058750 Powered by vancheer

All rights reserved Legal Statement Contact Us
XML 地图